Drug Shortage Prevention Act of 2025

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 2665 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 2665 To amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical drugs of increased demand, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES August 1, 2025 Ms. Klobuchar (for herself, Ms. Collins, Ms. Warren, Ms. Murkowski, Ms. Smith, and Mr. Peters) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical drugs of increased demand, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Drug Shortage Prevention Act of 2025''. SEC. 2. IMPROVING NOTIFICATION PROCEDURES IN CASE OF INCREASED DEMAND FOR CRITICAL DRUGS. (a…